Risk factors for relapse in childhood acute lymphoblastic leukemia: prediction and prevention
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Risk factors for relapse in childhood acute lymphoblastic leukemia: prediction and prevention
Authors
Keywords
-
Journal
Expert Review of Hematology
Volume 8, Issue 1, Pages 57-70
Publisher
Informa UK Limited
Online
2014-11-04
DOI
10.1586/17474086.2015.978281
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- 6MP adherence in a multiracial cohort of children with acute lymphoblastic leukemia: a Children's Oncology Group study
- (2014) S. Bhatia et al. BLOOD
- Outcome for children and young people with Early T-cell precursor acute lymphoblastic leukaemia treated on a contemporary protocol, UKALL 2003
- (2014) Katharine Patrick et al. BRITISH JOURNAL OF HAEMATOLOGY
- Pharmacogenetic considerations for acute lymphoblastic leukemia therapies
- (2014) Stéphanie Dulucq et al. Expert Opinion on Drug Metabolism & Toxicology
- Long-term follow-up of imatinib in pediatric Philadelphia chromosome-positive acute lymphoblastic leukemia: Children's Oncology Group Study AALL0031
- (2014) K R Schultz et al. LEUKEMIA
- TREATMENT OF ADOLESCENT AND YOUNG ADULTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA
- (2014) Josep-Maria Ribera et al. Mediterranean Journal of Hematology and Infectious Diseases
- IKZF1 status as a prognostic feature in BCR-ABL1-positive childhood ALL
- (2013) A. van der Veer et al. BLOOD
- Independent prognostic value of BCR-ABL1-like signature and IKZF1 deletion, but not high CRLF2 expression, in children with B-cell precursor ALL
- (2013) A. van der Veer et al. BLOOD
- Clinical Implementation of Germ Line Cancer Pharmacogenetic Variants During the Next-Generation Sequencing Era
- (2013) N K Gillis et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Clinical Pharmacogenetics Implementation Consortium Guidelines for Thiopurine Methyltransferase Genotype and Thiopurine Dosing: 2013 Update
- (2013) M V Relling et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Clinico-biological features of 5202 patients with acute lymphoblastic leukemia enrolled in the Italian AIEOP and GIMEMA protocols and stratified in age cohorts
- (2013) S. Chiaretti et al. HAEMATOLOGICA
- Impact of IKZF1 deletions on IKZF1 expression and outcome in Philadelphia chromosome negative childhood BCP-ALL. Reply to "Incidence and biological significance of IKZF1/Ikaros gene deletions in pediatric Philadelphia chromosome negative and Philadelphia chromosome positive B-cell precursor acute lymphoblastic leukemia"
- (2013) C. Palmi et al. HAEMATOLOGICA
- High modal number and triple trisomies are highly correlated favorable factors in childhood B-cell precursor high hyperdiploid acute lymphoblastic leukemia treated according to the NOPHO ALL 1992/2000 protocols
- (2013) K. Paulsson et al. HAEMATOLOGICA
- What is the relevance of Ikaros gene deletions as a prognostic marker in pediatric Philadelphia-negative B-cell precursor acute lymphoblastic leukemia?
- (2013) C. Palmi et al. HAEMATOLOGICA
- Successful tyrosine kinase inhibitor therapy in a refractory B-cell precursor acute lymphoblastic leukemia with EBF1-PDGFRB fusion
- (2013) E. Lengline et al. HAEMATOLOGICA
- Tyrosine Kinase Inhibitor Therapy Induces Remission in a Patient With Refractory EBF1-PDGFRB–Positive Acute Lymphoblastic Leukemia
- (2013) Brent W. Weston et al. JOURNAL OF CLINICAL ONCOLOGY
- Use of pharmacogenetics for predicting cancer prognosis and treatment exposure, response and toxicity
- (2013) Daniel L Hertz et al. JOURNAL OF HUMAN GENETICS
- Relapsed childhood acute lymphoblastic leukaemia
- (2013) Deepa Bhojwani et al. LANCET ONCOLOGY
- High-risk childhood acute lymphoblastic leukemia in first remission treated with novel intensive chemotherapy and allogeneic transplantation
- (2013) G M Marshall et al. LEUKEMIA
- An international study of intrachromosomal amplification of chromosome 21 (iAMP21): cytogenetic characterization and outcome
- (2013) C J Harrison et al. LEUKEMIA
- The MLL recombinome of acute leukemias in 2013
- (2013) C Meyer et al. LEUKEMIA
- An intragenic ERG deletion is a marker of an oncogenic subtype of B-cell precursor acute lymphoblastic leukemia with a favorable outcome despite frequent IKZF1 deletions
- (2013) E Clappier et al. LEUKEMIA
- ERG deletion is associated with CD2 and attenuates the negative impact of IKZF1 deletion in childhood acute lymphoblastic leukemia
- (2013) M Zaliova et al. LEUKEMIA
- The genomic landscape of hypodiploid acute lymphoblastic leukemia
- (2013) Linda Holmfeldt et al. NATURE GENETICS
- Relapse-specific mutations in NT5C2 in childhood acute lymphoblastic leukemia
- (2013) Julia A Meyer et al. NATURE GENETICS
- Activating mutations in the NT5C2 nucleotidase gene drive chemotherapy resistance in relapsed ALL
- (2013) Gannie Tzoneva et al. NATURE MEDICINE
- Genome-wide association study identifies germline polymorphisms associated with relapse of childhood acute lymphoblastic leukemia
- (2012) J. J. Yang et al. BLOOD
- Pediatric acute lymphoblastic leukemia: where are we going and how do we get there?
- (2012) C.-H. Pui et al. BLOOD
- Deep-sequencing approach for minimal residual disease detection in acute lymphoblastic leukemia
- (2012) M. Faham et al. BLOOD
- Genetic Alterations Activating Kinase and Cytokine Receptor Signaling in High-Risk Acute Lymphoblastic Leukemia
- (2012) Kathryn G. Roberts et al. CANCER CELL
- Minimal residual disease monitoring in childhood acute lymphoblastic leukemia
- (2012) Dario Campana CURRENT OPINION IN HEMATOLOGY
- Prediction of outcome by early bone marrow response in childhood acute lymphoblastic leukemia treated in the ALL-BFM 95 trial: differential effects in precursor B-cell and T-cell leukemia
- (2012) M. Lauten et al. HAEMATOLOGICA
- IKZF1 deletion is an independent predictor of outcome in pediatric acute lymphoblastic leukemia treated according to the ALL-BFM 2000 protocol
- (2012) P. Dorge et al. HAEMATOLOGICA
- The molecular basis of T cell acute lymphoblastic leukemia
- (2012) Pieter Van Vlierberghe et al. JOURNAL OF CLINICAL INVESTIGATION
- Improved Survival for Children and Adolescents With Acute Lymphoblastic Leukemia Between 1990 and 2005: A Report From the Children's Oncology Group
- (2012) Stephen P. Hunger et al. JOURNAL OF CLINICAL ONCOLOGY
- Imatinib after induction for treatment of children and adolescents with Philadelphia-chromosome-positive acute lymphoblastic leukaemia (EsPhALL): a randomised, open-label, intergroup study
- (2012) Andrea Biondi et al. LANCET ONCOLOGY
- Poor prognosis for P2RY8-CRLF2 fusion but not for CRLF2 over-expression in children with intermediate risk B-cell precursor acute lymphoblastic leukemia
- (2012) C Palmi et al. LEUKEMIA
- The genetic basis of early T-cell precursor acute lymphoblastic leukaemia
- (2012) Jinghui Zhang et al. NATURE
- Outcomes after Induction Failure in Childhood Acute Lymphoblastic Leukemia
- (2012) Martin Schrappe et al. NEW ENGLAND JOURNAL OF MEDICINE
- ATF5 polymorphisms influence ATF function and response to treatment in children with childhood acute lymphoblastic leukemia
- (2011) J. Rousseau et al. BLOOD
- Late MRD response determines relapse risk overall and in subsets of childhood T-cell ALL: results of the AIEOP-BFM-ALL 2000 study
- (2011) M. Schrappe et al. BLOOD
- Integrated genomic analysis of relapsed childhood acute lymphoblastic leukemia reveals therapeutic strategies
- (2011) L. E. Hogan et al. BLOOD
- RCSD1-ABL1-positive B lymphoblastic leukemia is sensitive to dexamethasone and tyrosine kinase inhibitors and rapidly evolves clonally by chromosomal translocations
- (2011) Koiti Inokuchi et al. INTERNATIONAL JOURNAL OF HEMATOLOGY
- Late Recurrence of Childhood T-Cell Acute Lymphoblastic Leukemia Frequently Represents a Second Leukemia Rather Than a Relapse: First Evidence for Genetic Predisposition
- (2011) Tomasz Szczepański et al. JOURNAL OF CLINICAL ONCOLOGY
- Biology, Risk Stratification, and Therapy of Pediatric Acute Leukemias: An Update
- (2011) Ching-Hon Pui et al. JOURNAL OF CLINICAL ONCOLOGY
- Study of the pharmacokinetic and pharmacogenetic contribution to the toxicity of high-dose methotrexate in children with acute lymphoblastic leukemia
- (2011) Noha M. EL-Khodary et al. MEDICAL ONCOLOGY
- CREBBP mutations in relapsed acute lymphoblastic leukaemia
- (2011) Charles G. Mullighan et al. NATURE
- Germline genetic variation and treatment response on CCG-1891
- (2011) Dana M. Sepe et al. PEDIATRIC BLOOD & CANCER
- Methotrexate consolidation treatment according to pharmacogenetics of MTHFR ameliorates event-free survival in childhood acute lymphoblastic leukaemia
- (2011) J Salazar et al. PHARMACOGENOMICS JOURNAL
- Minimal Residual Disease in Acute Lymphoblastic Leukemia
- (2011) D. Campana Hematology-American Society of Hematology Education Program
- Genetic rearrangements in relation to immunophenotype and outcome in T-cell acute lymphoblastic leukaemia
- (2010) Jules P.P. Meijerink BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY
- Identification of novel cluster groups in pediatric high-risk B-precursor acute lymphoblastic leukemia with gene expression profiling: correlation with genome-wide DNA copy number alterations, clinical characteristics, and outcome
- (2010) R. C. Harvey et al. BLOOD
- Molecular response to treatment redefines all prognostic factors in children and adolescents with B-cell precursor acute lymphoblastic leukemia: results in 3184 patients of the AIEOP-BFM ALL 2000 study
- (2010) V. Conter et al. BLOOD
- Clinical significance of low levels of minimal residual disease at the end of remission induction therapy in childhood acute lymphoblastic leukemia
- (2010) P. Stow et al. BLOOD
- Molecular pathogenesis and targeted therapies for NOTCH1-induced T-cell acute lymphoblastic leukemia
- (2010) Maddalena Paganin et al. BLOOD REVIEWS
- Application of genomics for risk stratification of childhood acute lymphoblastic leukaemia: from bench to bedside?
- (2010) Shai Izraeli BRITISH JOURNAL OF HAEMATOLOGY
- New Strategies in Acute Lymphoblastic Leukemia: Translating Advances in Genomics into Clinical Practice
- (2010) C. G. Mullighan CLINICAL CANCER RESEARCH
- Pharmacogenomics in pediatric leukemia
- (2010) Steven W Paugh et al. CURRENT OPINION IN PEDIATRICS
- Germline Genetic Variation, Cancer Outcome, and Pharmacogenetics
- (2010) Linda Coate et al. JOURNAL OF CLINICAL ONCOLOGY
- Long-Term Outcome in Children With Relapsed Acute Lymphoblastic Leukemia After Time-Point and Site-of-Relapse Stratification and Intensified Short-Course Multidrug Chemotherapy: Results of Trial ALL-REZ BFM 90
- (2010) Gesche Tallen et al. JOURNAL OF CLINICAL ONCOLOGY
- IKZF1 deletions predict relapse in uniformly treated pediatric precursor B-ALL
- (2010) R P Kuiper et al. LEUKEMIA
- Methotrexate/6-mercaptopurine maintenance therapy influences the risk of a second malignant neoplasm after childhood acute lymphoblastic leukemia: results from the NOPHO ALL-92 study
- (2009) K. Schmiegelow et al. BLOOD
- Adults with acute lymphoblastic leukemia and translocation (1;19) abnormality have a favorable outcome with hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone alternating with methotrexate and high-dose cytarabine chemotherapy
- (2009) Ravin Garg et al. CANCER
- Role of Minimal Residual Disease Monitoring in Adult and Pediatric Acute Lymphoblastic Leukemia
- (2009) Dario Campana HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA
- Genome-wide Interrogation of Germline Genetic Variation Associated With Treatment Response in Childhood Acute Lymphoblastic Leukemia
- (2009) Jun J. Yang JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Risk of Relapse of Childhood Acute Lymphoblastic Leukemia Is Predicted By Flow Cytometric Measurement of Residual Disease on Day 15 Bone Marrow
- (2009) Giuseppe Basso et al. JOURNAL OF CLINICAL ONCOLOGY
- Improved Early Event-Free Survival With Imatinib in Philadelphia Chromosome–Positive Acute Lymphoblastic Leukemia: A Children's Oncology Group Study
- (2009) Kirk R. Schultz et al. JOURNAL OF CLINICAL ONCOLOGY
- Early T-cell precursor leukaemia: a subtype of very high-risk acute lymphoblastic leukaemia
- (2009) Elaine Coustan-Smith et al. LANCET ONCOLOGY
- A subtype of childhood acute lymphoblastic leukaemia with poor treatment outcome: a genome-wide classification study
- (2009) Monique L Den Boer et al. LANCET ONCOLOGY
- Standardized MRD quantification in European ALL trials: Proceedings of the Second International Symposium on MRD assessment in Kiel, Germany, 18–20 September 2008
- (2009) M Brüggemann et al. LEUKEMIA
- Increased risk for CNS relapse in pre-B cell leukemia with the t(1;19)/TCF3-PBX1
- (2009) S Jeha et al. LEUKEMIA
- Deletion ofIKZF1and Prognosis in Acute Lymphoblastic Leukemia
- (2009) Charles G. Mullighan et al. NEW ENGLAND JOURNAL OF MEDICINE
- What determines the outcomes for adolescents and young adults with acute lymphoblastic leukemia treated on cooperative group protocols? A comparison of Children's Cancer Group and Cancer and Leukemia Group B studies
- (2008) W. Stock et al. BLOOD
- Clinical significance of minimal residual disease in childhood acute lymphoblastic leukemia and its relationship to other prognostic factors: a Children's Oncology Group study
- (2008) M. J. Borowitz et al. BLOOD
- Prospective Analysis ofTELGene Rearrangements in Childhood Acute Lymphoblastic Leukemia: A Children's Oncology Group Study
- (2008) Jeffrey E. Rubnitz et al. JOURNAL OF CLINICAL ONCOLOGY
- Prognostic Factors for Leukemic Induction Failure in Children With Acute Lymphoblastic Leukemia and Outcome After Salvage Therapy: The FRALLE 93 Study
- (2008) Caroline Oudot et al. JOURNAL OF CLINICAL ONCOLOGY
- BCR–ABL1 lymphoblastic leukaemia is characterized by the deletion of Ikaros
- (2008) Charles G. Mullighan et al. NATURE
- Genomic Analysis of the Clonal Origins of Relapsed Acute Lymphoblastic Leukemia
- (2008) C. G. Mullighan et al. SCIENCE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More